Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
9 Visualizações
• 08/09/23
0
0
Embutir
administrator
Assinantes
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários